Mehr finde ich auf die Schnelle nicht
www.kolloidales-silber-wasser.de/dateien...es_Silber_Kritik.pdf
www.zentrum-der-gesundheit.de
› Studien im Anhang
info.kopp-verlag.de/.../regierungen-beschlagnahmen-kolloidales-silber
1.Kaye, E. T., Topical antibacterial agents. Infect. Disease Clin. North America 14 (2000) 321.
2.Klasen, H. J., A historical review of the use of silver in the treatment of burns. Renewed interest for silver. Burns 26 (2000) 131-138.
3.Bhattacharya, R., Mukherjee, P., Biological properties of «naked« metal nanoparticles. Adv. Drug Delivery Rev. 60 (2008) 1289-1306.
4.von Nägeli, C. W., Über oligodynamische Erscheinungen in lebenden Zellen. Neue Denkschriften der schweizerischen naturforschenden Gesellschaft 33 (1893) 1-51.
5.Klasen, H. J., A historical review of the use of silver in the treatment of burns. Early uses. Burns 26 (2000) 117-130.
6.Zimmermann, W., Oligodynamische Silberwirkung. Über den Wirkungsmechanismus. Med. Microbiol. Immunol. 135 (1952) 403-413.
7.Kramer, A., New aspects in prophylaxis of ophthalmia neonatorum (Crede prophylaxis). Wien. Klin. Wschr. 114 (2002) 171-172.
8.Nel, A., et al., Toxic potential of materials at the nanolevel. Science 311 (2006) 622-627.
9.Lansdown, A. B. G., Silver in health care: antimicrobial effects and safety in use. Curr. Probl. Dermatol. 33 (2006) 17-34.
10.Russell, A. D., Hugo, W. B., Antimicrobial activity and action of silver. Prog. Med. Chem. 31 (1994) 351-370.
11.Alt, V., et al., In vitro testing of antimicrobial activity of bone cement. Antimicrobial Agents and Chemotherapy 48 (2004) 4084-4088.
12.Kim, K. J., et al., Antifungal effect of silver nanoparticles on dermatophytes. J. Microbiol. Biotechnol. 18 (2008) 1482-1484.
13.Mahnel, H., Schmidt, M., Effect of silver compounds on viruses in water. Zentralbl. Bakteriologie Mikrobiologie Hygiene, Serie B Umwelthygiene Krankenhaushygiene Arbeitshygiene, Präventive Medizin 182 (1986) 381-392.
14.IKW, Industrieverband Körperpflege und Waschmittel e. V., Kosmetika – Inhaltsstoffe Funktionen. Frankfurt 2005.
15.White, R. J., Cutting, K., Kingsley, A., Topical antimicrobials in the control of wound bioburden. Ostomy Wound Management 52 (2006) 26-58.
16.Leung, D. Y. M., et al., Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis evidence for a new group of allergens. J. Clin. Investigation 92 (1993) 1374-1380.
17.Leyden, J. J., Marples, R. R., Kligman, A. M., Staphylococcus aureus in lesions of atopic dermatitis. Brit. J. Dermatology 90 (1974) 525-530.
18.Ring, J., Abeck, D., Neuber, K., Atopic Eczema role of Microorganisms on the skin surface. Allergy 47 (1992) 265-269.
19.Palmer, C. N. A., et al., Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 38 (2006) 441-446.
20.Birnie, A. J., et al., Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst. Rev. (2008) CD003871.
21.Kunz, B., et al., Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195 (1997) 10-19.
22.Müller-Steinmann, J., et al., Prospective dermatologically controlled study of the efficacy of a silver containing nurturing cream (MicroSilver BGTM 0.1 Prozent) in atopic dermatitis. Kosmet. Med. 28 (2008) 208-212.
23.Drake, P. L., Hazelwood, K. J., Exposure-related health effects of silver and silver compounds: A review. Ann. Occupational Hygiene 49 (2005) 575-585.
24.Benetka, E., Determination of the silver content in sellotapes after application of silver containing ointment on human skin. Nicht veröffentlichter Report 2007.
25.U. S. EPA, Silver.
www.epa.gov/iris/